Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Vaccine Année : 2005

Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming.

Résumé

Plants have become, over the last ten years, a suitable alternative to microbial and animal cell factories for the production of clinically-useful, therapeutic proteins. Besides the well known advantage of low-cost and large-scale production of safe and biologically active mammalian proteins, plants also are able to perform most post-translational maturations required for biological activity and suitable pharmacokinetics of recombinant therapeutic proteins. In this short review we focus on glycosylation and proteolytic processing of plant-made pharmaceuticals during their transport through the plant cell's secretory pathway. We also address the practical implications of these important processes on the effectiveness of plant molecular pharming systems.

Dates et versions

hal-01942853 , version 1 (03-12-2018)

Identifiants

Citer

Loic Faye, Aurélia A. Boulaflous, Meriem Benchabane, Veronique Gomord, Dominique Michaud. Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming.. Vaccine, 2005, 23 (15), pp.1770-8. ⟨10.1016/j.vaccine.2004.11.003⟩. ⟨hal-01942853⟩
33 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More